Shree Ganesh Remedies trades jubilantly on executing supply agreement with Japanese firm
Shree Ganesh Remedies is currently trading at Rs. 830.90, up by 89.50 points or 12.07% from its previous closing of Rs. 741.40 on the BSE.
The scrip opened at Rs. 889.65 and has touched a high and low of Rs. 889.65 and Rs. 772.60 respectively. So far 52834 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 950.05 on 26-Jul-2024 and a 52 week low of Rs. 557.95 on 15-May-2024.
Last one week high and low of the scrip stood at Rs. 889.65 and Rs. 621.10 respectively. The current market cap of the company is Rs. 1060.39 crore.
The promoters holding in the company stood at 72.80%, while Institutions and Non-Institutions held 0.01% and 27.19% respectively.
Shree Ganesh Remedies (SGRL) has executed long-term Strategic Supply Agreement (SSA) with one of the foremost players in the Japanese market. The agreement, formalised on January 30, 2025, is set for an initial term of three years, with the potential for extension by an additional two years.
Under this strategic partnership, SGRL will engage in contract manufacturing for a total of three innovative products, which are poised to make their debut as the first of their kind in India. These products will be developed employing advanced methodologies in Chlorination and Reduction chemistry.
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
.jpg)
